FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q90481872> ?p ?o ?g. }

• Q90481872 description "2019 nî lūn-bûn" @default.
• Q90481872 description "2019年の論文" @default.
• Q90481872 description "2019年学术文章" @default.
• Q90481872 description "2019年学术文章" @default.
• Q90481872 description "2019年学术文章" @default.
• Q90481872 description "2019年学术文章" @default.
• Q90481872 description "2019年学术文章" @default.
• Q90481872 description "2019年学术文章" @default.
• Q90481872 description "2019年學術文章" @default.
• Q90481872 description "2019年學術文章" @default.
• Q90481872 description "2019年學術文章" @default.
• Q90481872 description "2019年學術文章" @default.
• Q90481872 description "2019年學術文章" @default.
• Q90481872 description "2019년 논문" @default.
• Q90481872 description "article científic" @default.
• Q90481872 description "article scientific" @default.
• Q90481872 description "article scientifique" @default.
• Q90481872 description "articol științific" @default.
• Q90481872 description "articolo scientifico" @default.
• Q90481872 description "artigo científico" @default.
• Q90481872 description "artigo científico" @default.
• Q90481872 description "artigo científico" @default.
• Q90481872 description "artikel ilmiah" @default.
• Q90481872 description "artikull shkencor" @default.
• Q90481872 description "artikulong pang-agham" @default.
• Q90481872 description "artykuł naukowy" @default.
• Q90481872 description "artículo científico publicado en 2019" @default.
• Q90481872 description "artículu científicu" @default.
• Q90481872 description "bilimsel makale" @default.
• Q90481872 description "bài báo khoa học" @default.
• Q90481872 description "naučni članak" @default.
• Q90481872 description "scienca artikolo" @default.
• Q90481872 description "scientific article published in October 2019" @default.
• Q90481872 description "scientific article published in October 2019" @default.
• Q90481872 description "scientific article published on 01 October 2019" @default.
• Q90481872 description "teaduslik artikkel" @default.
• Q90481872 description "tieteellinen artikkeli" @default.
• Q90481872 description "tudományos cikk" @default.
• Q90481872 description "vedecký článok" @default.
• Q90481872 description "vetenskaplig artikel" @default.
• Q90481872 description "videnskabelig artikel udgivet oktober 2019" @default.
• Q90481872 description "vitenskapelig artikkel" @default.
• Q90481872 description "vitskapeleg artikkel" @default.
• Q90481872 description "vědecký článek" @default.
• Q90481872 description "wetenschappelijk artikel" @default.
• Q90481872 description "wissenschaftlicher Artikel" @default.
• Q90481872 description "επιστημονικό άρθρο" @default.
• Q90481872 description "мақолаи илмӣ" @default.
• Q90481872 description "наукова стаття, опублікована в жовтні 2019" @default.
• Q90481872 description "научна статия" @default.
• Q90481872 description "научная статья" @default.
• Q90481872 description "научни чланак" @default.
• Q90481872 description "научни чланак" @default.
• Q90481872 description "מאמר מדעי" @default.
• Q90481872 description "مقالة علمية نشرت في أكتوبر 2019" @default.
• Q90481872 description "অক্টোবর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q90481872 description "บทความทางวิทยาศาสตร์" @default.
• Q90481872 description "სამეცნიერო სტატია" @default.
• Q90481872 name "Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials" @default.
• Q90481872 name "Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials" @default.
• Q90481872 type Item @default.
• Q90481872 label "Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials" @default.
• Q90481872 label "Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials" @default.
• Q90481872 prefLabel "Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials" @default.
• Q90481872 prefLabel "Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials" @default.
• Q90481872 P1433 Q90481872-ABA499E9-32B8-4EDE-88C5-79D3035EB2DD @default.
• Q90481872 P1476 Q90481872-4326874D-5973-4AF3-967F-2E1151B751FD @default.
• Q90481872 P2093 Q90481872-261EA003-9654-4D02-93CE-80796C16B803 @default.
• Q90481872 P2093 Q90481872-40135A66-1E04-4FAD-9CFF-1BFC1B2E3C8C @default.
• Q90481872 P2093 Q90481872-705014BB-11AE-4D5A-BD50-73ED3E97B128 @default.
• Q90481872 P2093 Q90481872-865E2E36-F93F-4A22-BD0C-B806107C762D @default.
• Q90481872 P2093 Q90481872-DD144C68-18FC-4016-923D-8221B584ACDD @default.
• Q90481872 P304 Q90481872-FC811A6A-5D3B-4BDC-95AB-8C93CD1941E5 @default.
• Q90481872 P31 Q90481872-45129E77-B92F-4FD4-A839-7F585FDF4996 @default.
• Q90481872 P433 Q90481872-55C21B77-C916-477A-BBEA-1F1E892E968D @default.
• Q90481872 P478 Q90481872-E29CE8D2-EF6E-446E-8D4C-E347660082A3 @default.
• Q90481872 P577 Q90481872-C1139179-234C-454A-9D0E-15E157E5967D @default.
• Q90481872 P698 Q90481872-6603CCC6-BDA6-484C-BF45-CE8C12CC2A14 @default.
• Q90481872 P921 Q90481872-77609040-3117-4F11-9C1D-900C12E75F2C @default.
• Q90481872 P921 Q90481872-CA20039E-6BF9-40A7-9678-60964C0C1144 @default.
• Q90481872 P698 31584780 @default.
• Q90481872 P1433 Q25380091 @default.
• Q90481872 P1476 "Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials" @default.
• Q90481872 P2093 "Jeffrey L. Sugarman" @default.
• Q90481872 P2093 "Linda Stein Gold" @default.
• Q90481872 P2093 "Mark G. Lebwohl" @default.
• Q90481872 P2093 "Robert Israel" @default.
• Q90481872 P2093 "Tina Lin" @default.
• Q90481872 P304 "1012-1018" @default.
• Q90481872 P31 Q13442814 @default.
• Q90481872 P433 "10" @default.
• Q90481872 P478 "18" @default.
• Q90481872 P577 "2019-10-01T00:00:00Z" @default.
• Q90481872 P698 "31584780" @default.
• Q90481872 P921 Q10355321 @default.
• Q90481872 P921 Q42824827 @default.